Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cameron Currant might have never intended to commercialize LZ. His modus operandi has been to take promising drugs and turn them into a vehicle to dilute shareholders of the Company by making private stock sales to chrony investors who are offered the stock at below market prices and told the price they can buy with the plan to Short sell the stock prior to the offering then cover the short shares with the offering shares.
Sounds like racketeering right? Well it is perfectly legal and Cameron Currant and many others have made themselves and a lot of short selling legal Racketeers a lot of money over the years. He ran Anavex Life Sciences into near oblivion to $.41 cents before the currant CEO took over. His current company is KBIO but under a different name, but the same scam as he always does. No wonder the short sellers of CYDY love that company as its CEO rapes legally the shareholders for the benefit of short sellers of its stock.
LZ is an interesting drug for research but it is not a viable drug to commercialize because the Company that sponsors it has no ability to produce the drug in commercial quantities. CytoDyn has enough already produced drug to begin shipping commercial quantities and Samsung can produce much more currently and Samsung is also expanding their production capacity three fold currently. Samsung will be ready to ramp up production considerably in 6 to 12 months. Plans are being layed and ground has already been broken on a super modern new Samsung biologics.
production facility.
CytoDyn has capability to produce LL through Samsung in the initial quantities needed to gain market share.
That and as you pointed out LZ trials met meaningless endpoints.
What is it called when a Company files for a EUA for it drug knowing it could never get an EUA from the FDA because they have no ability to produce the drug in meaningful quantities and yet files for EUA anyway leading investors down the primrose path. A lot of amateur investors got their teeth kicked in on that one. No wonder they are obsessed with what they perceive as a chipped tooth on the CEO of CytoDyn.
Stocks of pre revenue companies under development are analogous to undeveloped real estate except the long holders of the stocks have no property tax bills to pay. CYDY is not marginable so longs are not on margin and most long holders likely much greater than 90% have no margin debts on CYDY while all short holders have a minimum of $2.50 in margin debt on every share they hold short. That $2.50 per share can be liquidated out of the short holders account in a flash while long holders can and have been accumulating at all different prices averaging both up and down dollar cost averaging over multiple years time. It can go back down to $ .33 and long holders can simply buy more or continue to hold. If CYDY appreciates 5x or 10x on a partnership deal over night a short seller, and 100% of short shares by their very nature are all on margin, could lose all the securities held as collateral plus face a deficiency. Short sellers of CYDY are a heart beat away from bankruptcy. CYDY is rapidly developing and could ink a deal any day now.
If it takes longer than expected it may just be a bigger bang when it does happen and long stock holders are comfortablely bidding their time while Short sellers are literally sweating bullets while playing Russian Roulette and paying interest on borrowed shares. No wonder the issue of bankruptcy keeps coming up.
It seems the underwater short sellers are hoping for some miracle to happen out of the blue to save their losing short bet. Some totally impossible extreme thing like Dr Scott Kelly to be convicted of a crime or an out of the blue bankruptcy filing. The short sellers are becoming more and more delusional as they are squeezed slowly and inextricably with continued positive developments in CYDY. They were so arrogant and convinced that CytoDyn was a Scam that they when all in on short positions early on and stubbornly refuse to face the facts, they stand to be financially annihilated by the next big positive surprise. The short sellers are defeated yet they hang in there for further losses and the possibility of a sudden and catastrophic wipeout with the next big positive development for CYDY. Russian Roulette with five bullets in the chambers of a six shooter.
200 million shares allows a a deal to be made with a Bigger Pharma to buy a stake in CYDY at say 50 million shares at $10 a share and split profits on the indication that is the subject of the partnership. $500 million plus milestones. CYDY would then have a market cap approaching $10 billion and uplift to NASDAQ would be in the bag.. Further appriecation in share price after further regulatory successes might allow further tranches of shares to be sold at $20 per share or higher. Once the trials in Brazil readout CYDY might easily 5x or 10x in a matter of 6 months or less.
I am accumulating CYDY.
Don't blink!
CYDY could go on an epic run late this year or early 2022.
Rolling margin calls on short positions and immediately called loans of shorted shares. Outlook will be bleak as the funds that backed the shorts margin neccessarliy would the be in long positions in other stocks or cash. But it would not be cash because the shorts arrogantly think they are the smartest traders in the market. Everything else practically fell including the big techs, especially the big techs. Ultimate short nightmare resulting in a very humbling wipe out as the overall market corrects downward while a few select heavy shorted stocks including CYDY skyrocket. Short positions in skyrocketing CYDY with no cash to cover so fire sell long position resulting in totally liquidated accounts with a lingering debt to be levied on other assets and accounts. CYDY Short sellers on the brink of bankruptcy.
Some deluded short sellers will and are committing financial suicide.
No InCellDX tests have been put through any clinical trials. So no approvals from FDA and have not even started the process.
Never mind I get the joke.
I enjoy your posts ER. Please indulge my lack of knowledge of Ted Lasso, I assume he is a business executive. Please thumb nail bio please.
The development of Leronlimab has been actually very good, faster and less expensive than most. It is on the cusp of being proved in more indications. Already the HIV indication was proved in Phase 3. Just needs the final BLA piece of the puzzle. The Covid indication could quite quickly result in billions in revenue. That will be the time to transfer the CEO role to someone good at directing a Revenue Generating Biotech. Nader will be a multi billionaire and will do what is best for CytoDyn and his fellow shareholders. For now we need a CEO who is good at raising funds pre Revenue. That man is Nader one of the best in the world who has grown CytoDyn into the one of largest by market cap pre revenue biotech on the OTC.
Those that can not see the value in CYDY might be inexperience biotech investors or simply disingenuous short sellers.
What ever could be said of Nader pro or con ( everybody has pros and cons ) Nader is an absolutely F ing genius on raising money in an OTC stock. There maybe no one better in the world bar non. He will be legendary for THIS and for Leronlimab. No one else but a Elon Musk type of recently super focused legend or master freaking salesman of the same caliber as Nader. Nader is simply the best in the world at raising money on the OTC.
That is what above all else determines success in a pre-revenue biotech. But all that is for naught is not for a worthy and. attainable target of revenue.
Leronlimab might become one of the most valuable drugs in the future.
CytoDyn has a world class CEO at raising money for a small biotech and a world class drug. CEO Nader just proved he can fund Leronlimab to development. Does anyone seriously doubt that Leronlimab will be valuable in multiple indications?
Interesting thought. I thought it was conservative and careful long investors adding to their positions and savvy short sellers covering short positions on the news that CYDY is able to raise the money it needs by minute sized dilution and the Brazil trials starting in earnest.
Currently CYDY is the hottest prospect for massive stock gains both from short term trading going long and from LT Hold of 3 to 5 years where the real wealth will be made.
CYDY is not going on a multiday run. It is taking off on an incredible 12-18 month run to its true market value as proved by the Brazil trials and other catalysts.
Well said. Respect! What a beautiful thought. CYDY is a long time keeper.
CYDY up 15%+ on 4 million shares. Short sellers...go on an git!
Massive breakout to the upside 1.27 million shares in the first hour. Investors are starting to see this as the gold mine it is. Here comes the Gold Rush days.
Yes that was little Timmy Sykes and band of can't shoot straight petty Racketeers. They are the ones who will get prosecuted and they can not even squeel on the big Mob bosses because they know nothing except what they were told by the Mob.
It was designed as a cover most likely. But the short sellers got greedy and started to sell early to get in front of the other short sellers. So they blew their cover and it is like a smoking gun brought on by their greed. If they bring them to trial it will be close to 100% chance of conviction.
Do you mean like the August sabbatical for Adam Feuerstien from which he has not returned even it is Septeber 16th? Around that time they disappeared?
Data. Scientific facts. And above ALL results. RULE.
Thanks for the Google search trends DATA.
Search trends= interest=possible investments
Best estimate is around 120 enrolled at two weeks to 240. Iterim analysis of the first 40% in expected just before Christmas Day 2021.
Whata boowwtit? First patient was dosed more than a week ago. All 20 sites would have many patients waiting. Estimates could range from 4 to 12 patients on average per site for a total of 80 to 240 patients with the first dose with approx 1/7 of that original number after the first week getting there second dose every day there after. This will be the first two or three weeks. After that if patients respond as they have always responded then there will be a rush of new trial participants because good news of rapid recoveries will spread Brazil wide and World wide. If one is not either in the stock or at least had covered their short positions....well imagine.
Well it is currently Friday 9-17 4.17 am in Phils. So if it already happened.
The new equity raise might put CYDY over the hump of cash required to uplist to NASDAQ.
Kathy Wood's ARK investments have been liquidating Pluristem holdings. A formerly emerging Covid play. She or another well known Institution/ETF might go BIG CYDY on a Nasdaq uplisting. This Nasdaq event might happen as a surprise.
HGEN siips further into the Abyss as CytoDyn races higher with the well designed Brazil trials. If one is on the wrong side of this some corrective action might be warranted. Congradulations to those HGEN investors who hedged with some long CytoDyn.
CYDY looks to be in a high volume reversal so those that wish CYDY to fail are possibly making negative things up during this reversal to the upside based on the Brazil Trials gaining momentum.
Well. Generally Defendants in a civil suit are usually granted first opportunity to take depositions. It is done out of convention. It is decided at a discovery conference with the Judge. Much later ta pretrial order is entered by the Judge comprised of discovery deadlines, requests for further depositions, list of witnesses and a definitive recitation of the Plaintiff Party's claims and the affirmative defenses of the various Defendant Parties.
Early on there will be a Discovery Order setting out the Order of Discovery. Defendants are almost always allowed to go first.
Anyone that thinks it is ominous that the CEO of a Plantiff Corporation would be deposed is just so uninformed as to be confused about anything involving litigation.
"1907 I think the B-52 was already flying back then" HaHa close. Boeing business plans and aircraft designs are projected 50 years into the future. So about right for the genesis of the planning stage.
When will HGEN get their EUA? Answer might be the 12th of Never. Sad but true.
These are some very provocative and interesting musings. It seems the Goverment corroption is accelerating faster than the concentration of wealth into the hands of the .001 % at the top.
Tyranny of the Corporate Oligarchs in the USA. Same as China and Russia.
Both are useful promising drugs. Both are victims of shortsighted bureaucrats and possibly Corona War Profiteers from Big Pharma and their rackeering influenced Goverment bribed bureaucrats.
HGEN was a great investment myth. Reality is both CYDY and HGEN are victims of the USA vaccinations for all at any cost to public health reality.
Everyone is USA vaccinated with a mRNA type spoke protein vaccination and everyone in China and Russia vaccinated with a deactivated virus traditional vaccine creates a dangerous dichotomy where the spike proteins circulating in the USA population could be exploited by future bioweapons.
I am listening for the for rumblings of the terrestrial form of explosive leviathan.
Anak Krakatoa. Child of Krakatoa.
Eruption of NWBO might leave no time to cover.
The 13D premature proxy solicitation was a major and fatal tactical and strategic error. They can Not do a second one. This one was DOA because not timed right. They will not be allowed to issue a second one. Such silly and amateur confusion from the 13D dummies. But they knew the lawsuit will prevent them from doing a proper proxy anyway. Therefore this last gasp impotent proxy solicitation. As the Company said and the Court will order later. Disregard the proxy cards from these corporate raiders.
This seems like a cut and paste from buyerstrike.com. A disreputable short seller like Citron and a possible RICO market manipulator. One must feel immune from the long arm of the Law to repeat such rubbish.
Yes you were right.